{ "company_number": "10650475", "name": "Ottimo Pharma Limited", "url": "/company/10650475", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2017-03-03", "dissolved_on": null, "sic_codes": [ { "code": "72110", "description": "Research and experimental development on biotechnology", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/72110" } ], "registered_address": { "id": 437837, "url": "/address/437837", "line1": "C/O KRESTON REEVES LLP INNOVATION HOUSE", "line2": "RAMSGATE ROAD", "post_town": "SANDWICH", "county": "KENT", "country": "UNITED KINGDOM", "postcode": "CT13 9FF" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10650475", "previous_names": [ { "name": "Ultrahuman Eight Limited", "ceased_on": "2024-09-23" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-09-30", "last_made_up": "2025-12-31", "category": "GROUP", "filings": [ { "url": "/company/10650475/accounts/2025-12-31", "pdf_url": "/company/10650475/accounts/2025-12-31.pdf", "made_up_date": "2025-12-31", "period_start": "2025-01-01", "period_end": "2025-12-31", "entity_name": "Ottimo Pharma Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "5288666.00", "debtors": "6627516.00", "cash_bank_in_hand": "82356857.00", "current_assets": "88984373.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "79267516.00", "total_assets_less_current_liabilities": "84556182.00", "net_assets_liabilities": "84556182.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "172.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-35346914.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2026.zip" }, { "url": "/company/10650475/accounts/2023-12-31", "pdf_url": "/company/10650475/accounts/2023-12-31.pdf", "made_up_date": "2023-12-31", "period_start": "2023-12-31", "period_end": "2023-12-31", "entity_name": "Ottimo Pharma Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": "175603.00", "cash_bank_in_hand": "984841.00", "current_assets": "1160444.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "980052.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "980052.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "68.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2024.zip" }, { "url": "/company/10650475/accounts/2020-12-31", "pdf_url": "/company/10650475/accounts/2020-12-31.pdf", "made_up_date": "2020-12-31", "period_start": "2020-12-31", "period_end": "2020-12-31", "entity_name": "Ultrahuman Eight Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": "138144.00", "cash_bank_in_hand": "4313392.00", "current_assets": "4451536.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4328884.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "4328884.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "66.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2021.zip" }, { "url": "/company/10650475/accounts/2019-12-31", "pdf_url": "/company/10650475/accounts/2019-12-31.pdf", "made_up_date": "2019-12-31", "period_start": "2019-01-01", "period_end": "2019-12-31", "entity_name": "Ultrahuman Eight Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": "14844.00", "cash_bank_in_hand": "67108.00", "current_assets": "81952.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "77032.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "77032.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "10.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-89897.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2020.zip" }, { "url": "/company/10650475/accounts/2018-12-31", "pdf_url": "/company/10650475/accounts/2018-12-31.pdf", "made_up_date": "2018-12-31", "period_start": "2018-01-01", "period_end": "2018-12-31", "entity_name": "Ultrahuman Eight Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": "68708.00", "cash_bank_in_hand": "103872.00", "current_assets": "172580.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "166930.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "166930.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "10.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-259034.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2019.zip" }, { "url": "/company/10650475/accounts/2017-12-31", "pdf_url": "/company/10650475/accounts/2017-12-31.pdf", "made_up_date": "2017-12-31", "period_start": "2017-03-03", "period_end": "2017-12-31", "entity_name": "Ultrahuman Eight Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": "84572.00", "cash_bank_in_hand": "413355.00", "current_assets": "497927.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "425964.00", "total_assets_less_current_liabilities": "425964.00", "net_assets_liabilities": "425964.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "10.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-265038.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2018.zip" } ], "pdf_only_filings": [ { "made_up_date": "2024-12-31", "filing_date": "2025-05-16", "form_type": "AAMD", "description": "accounts-amended-with-accounts-type-small", "paper_filed": true, "pdf_url": "/company/10650475/accounts/2024-12-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10650475/filing-history/MzQ2NjY5NDcyMmFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2022-12-31", "filing_date": "2023-10-09", "form_type": "AA", "description": "accounts-with-accounts-type-small", "paper_filed": true, "pdf_url": "/company/10650475/accounts/2022-12-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10650475/filing-history/MzM5NTUzNzY5NmFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2021-12-31", "filing_date": "2022-08-19", "form_type": "AA", "description": "accounts-with-accounts-type-small", "paper_filed": true, "pdf_url": "/company/10650475/accounts/2021-12-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10650475/filing-history/MzM0OTE1OTEyOWFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10650475/filing-history" }, "confirmation_statement": { "next_due": "2027-02-04", "last_made_up": "2026-01-21" }, "officers": [], "psc": [ { "name": "Dr James Edward Coleman", "kind": "individual-person-with-significant-control", "person_url": "/person/2118842", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2017-03-03", "ceased_on": "2017-04-06", "nationality": "British", "country_of_residence": "Scotland", "source": "snapshot" }, { "name": "Dr William James Jonathan Finlay", "kind": "individual-person-with-significant-control", "person_url": "/person/5236846", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent", "voting-rights-50-to-75-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2017-03-03", "ceased_on": "2017-04-06", "nationality": "British", "country_of_residence": "Scotland", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-13T04:42:39.010227+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }